Described by some as radical and others as merely progressive, HIPEC is a hot topic for some oncologists.

In late April of this year, the CCAC conducted a highly successful and effective meeting with some of the country’s most influential surgical oncologists, and we are pleased to announce that the formation of the Canadian HIPEC Collaborative Group was a result of this meeting. The consensus statement generated at the meeting is scheduled to be publicized in medical oncology journals and posted on the CCAC website in fall of 2010. We are confident that this group will become a world leader in research and data capture on the subject of the treatment!

During the fascinating HIPEC treatment procedure, the patient’s abdomen is opened surgically and a heated sterile solution of chemotherapy (such as mitomycin c, cisplatin, 5FU and oxaliplatin) is introduced into the cavity. The organs are continually bathed in the solution for a maximum of two hours. It is especially useful when cancer has spread to the peritoneum, the saran wrap-like lining of the abdomen, because this particular organ receives little blood flow and doesn’t respond well to traditional chemotherapy. The peritoneum is a common metastatic site for colorectal cancer patients.

Click here to read more about HIPEC treatment for peritoneal metastasis.